prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |review
Recent landmark coronary prevention studies utilizing the statin class of drugs have conclusively demonstrated the benefit of lowering low density lipoprotein cholesterol (LDL-C) in reducing morbidity and mortality from coronary heart disease (CHD).

* Nonfatal MI/CHD death Primary Prevention

Secondary Prevention ** Normal cholesterol levels

The Lancet 1994;344:1383-1389 JAMA 1998:279:1615-1622.

N Engl J Med 1995;333:1301-1307. N Engl J Med 1998;339:1329-1357

N Engl J Med 1996;335:1001-1009